Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.


(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...


(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...


Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...


LONDON (Alliance News) - ANGLE PLC said Monday it appointed urological surgeon, Greg Shaw, as a scientific advisor.The liquid biopsy company appointed...


LONDON (Alliance News) - ANGLE PLC on Thursday said its Parsortix system has developed an optimised workflow for the recovery and culturing of circula...


* ANZ falls for the eighth straight day * Fonterra slightly lower after NZ milk production falls in Feb By Susan Mathew April 4 (Reuters) - Australian...


* No formal offer received - AGL * Liddell slated to be closed in 2022 * Australia government sought Alinta's interest (Adds fresh Alinta MD quote, Ap...


LONDON (Alliance News) - Liquid biopsy firm ANGLE PLC shares climbed on Monday as it said results from a study into is pelvic mass triage test showed ...


March 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Capital & Counties Propertie...


MILAN, March 9 (Reuters) - European private equity firm OpCapita said on Friday it had reached a deal to buy the majority of Sebeto, an Italian restau...


(ShareCast News) - Medical technology company Angle has been chosen to take part in Cancer-ID, a European consortium to validate blood-based biomarker...